Akoya Biosciences, Inc.’s Post

This week on BackTable Urology, Dr. Seth Lerner (Baylor College of Medicine) discusses the intricacies of lymph node dissection in bladder cancer management, including an overview of patterns of metastasis, genomic classifiers, and recent clinical trials. The discussion highlights the evolution of bladder cancer treatment, from the use of cytotoxic chemotherapy to the current practice of neoadjuvant chemotherapy and radical cystectomy. Dr. Lerner and Dr. Bagrodia further explore diagnostic and treatment strategies, including the role of Decipher Prostate Genomic Classifier in tailoring patient treatment plans. The podcast delves into the necessity of a multidisciplinary approach to bladder cancer, the benefits of multimodal therapy, and the integration of circulating tumor DNA in management plans. Dr. Lerner then discusses clinical trials assessing the impact of extended lymph node dissection during cystectomies and emphasizes the importance of surgical quality and adherence to established protocols in bladder cancer treatment. Listen now: https://lnkd.in/gMybp7pT #bladdercancer #bladderhealth #urology #urologist #meded #medtech #backtable Decipher by Veracyte

medical innovation at our core

This week on BackTable Urology, Dr. Seth Lerner (Baylor College of Medicine) discusses the intricacies of lymph node dissection in bladder cancer management, including an overview of patterns of metastasis, genomic classifiers, and recent clinical trials. The discussion highlights the evolution of bladder cancer treatment, from the use of cytotoxic chemotherapy to the current practice of neoadjuvant chemotherapy and radical cystectomy. Dr. Lerner and Dr. Bagrodia further explore diagnostic and treatment strategies, including the role of Decipher Prostate Genomic Classifier in tailoring patient treatment plans. The podcast delves into the necessity of a multidisciplinary approach to bladder cancer, the benefits of multimodal therapy, and the integration of circulating tumor DNA in management plans. Dr. Lerner then discusses clinical trials assessing the impact of extended lymph node dissection during cystectomies and emphasizes the importance of surgical quality and adherence to established protocols in bladder cancer treatment. Listen now: https://lnkd.in/gkJkMd-A #bladdercancer #bladderhealth #urology #urologist #meded #medtech #backtable Siamak Daneshmand John Sfakianos Mark Preston Mohit Khera Richard Link Badar M. Mian Alexander Kutikov, MD, FACS Mohummad Minhaj Siddiqui Mary Beth Westerman Phillip Pierorazio Javier-DesLoges Juan Aaron Fritts MD Bryant Schmitz Quynh-Chi (Chi) Dang Quoc-Dien Trinh David Canes Decipher by Veracyte

📢 Take a look at our latest article published in European Urology Open Science! Read more about how can we improve patient-clinician communication for men diagnosed with #ProstateCancer? PIONEER - Big Data in Prostate Cancer To the article: 👇 👇 👇 https://lnkd.in/evJAH37F

Did you know prostate cancer is the second most common cancer among men? This month, Chesapeake Urology is on a mission to help you understand this disease and take better care of your prostate. Watch this space for valuable tips, information, and resources. #ProstateCancerAwarenessMonth

This Prostate Cancer Awareness Month, ArborMetrix is proud to support our partners, including ConDUC Urology, the Pennsylvania Urology Regional Collaborative (PURC) and MUSIC Urology, who are making significant strides in the fight against prostate cancer. By harnessing the power of real-world data and advanced analytics, we're helping healthcare providers make informed decisions that improve outcomes and enhance the quality of prostate cancer care.   Together, we're transforming data into actionable insights, optimizing treatment pathways, and driving better health for patients. Early detection and personalized care can make all the difference.   #ProstateCancerAwareness #DataDrivenCare #ArborMetrix #BetterOutcomes #UrologyCare #PatientHealth #HealthcareAnalytics   Links: - (https://lnkd.in/e_sJ7RNA) - (https://lnkd.in/eNWEXV-j) - (https://musicurology.com/)

Did you know prostate cancer is the second most common cancer among men? This month, United Urology Group is on a mission to help you understand this disease and take better care of your prostate. Watch this space for valuable tips, information, and resources. #ProstateCancerAwarenessMonth

Spotlighting HIFU physicians across the US sheds light on urologists enhancing communities by offering HIFU for men with localized prostate cancer. In a recent interview, James Bienvenu, MD from University Urology and UT Medical Center in Knoxville, Tennessee, shares insights on prostate cancer diagnosis, focal therapies, and the impact of HIFU in the landscape. Dr. Bienvenu highlights how HIFU spares crucial prostate areas, maintaining erections and urinary control. Patients recover swiftly post-catheter removal with minimal side effects, showcasing the efficacy of this treatment. HIFU Prostate Services enjoys working with Dr. Bienvenu and his team at UTMC to provide Sonablate HIFU in TN, ensuring patient accessibility and educating urologic residents on its benefits. Explore more about Dr. Bienvenu's pioneering work in prostate cancer treatment: https://lnkd.in/eaM4kVXM #healthcare #prostatecancer #urology #hifu #patientcare #qualityoflife #cancertreatment #Sonablate #hospitals #experience #minimallyinvasive

Did you know prostate cancer is the second most common cancer among men? This month, Tennessee Urology is on a mission to help you understand this disease and take better care of your prostate. Watch this space for valuable tips, information, and resources. #ProstateCancerAwarenessMonth

Day 2 of the European Association of Urology congress! Feel free to stop by our booth E36 to discover our Trinity system! Don’t miss out the following abstract sessions: 🎓 Sunday, April 7th at 3:45pm: « Treatment of benign prostatic hyperplasia by transperineal targeted microwave guided by 3D ultrasound; first safety and feasibility » by Dr Peter Ka-Fung Chiu (HK) 🎓 Monday, April 8th at 10:45am: « Targeted microwave ablation for localized prostate cancer (Fostine 1b): a prospective study of ablation and resection by Prof Alexandre Peltier (BE)